FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

EA van Royen

Research Profile

Procedures

Single-Photon Emission-Computed Tomography

Chemicals & Drugs

Anatomy

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ania Winogrodzka; PL Bergmans; Jan Booij; EA van Royen; JC Stoof; Erik C Wolters
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Ania Winogrodzka; Robert C Wagenaar; PL Bergmans; Astrid Vellinga; Jan Booij; EA van Royen; Richard E A van Emmerik; JC Stoof; Erik C Wolters
Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.
Jules Lavalaye; Jan Booij; Don Linszen; Liesbeth Reneman; EA van Royen
Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of EA van Royen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Ania Winogrodzka; PL Bergmans; Jan Booij; EA van Royen; JC Stoof; Erik C Wolters
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2003;74(3):294-8.
2001: Ania Winogrodzka; Robert C Wagenaar; PL Bergmans; Astrid Vellinga; Jan Booij; EA van Royen; Richard E A van Emmerik; JC Stoof; Erik C Wolters
Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients.
Movement disorders : official journal of the Movement Disorder Society 2001;16(6):1033-40.
2001: Jules Lavalaye; Jan Booij; Don Linszen; Liesbeth Reneman; EA van Royen
Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study.
Psychopharmacology 2001;156(1):53-7.
2001: Jules Lavalaye; A Sarlet; Jan Booij; Don Linszen; Liesbeth Reneman; Berthold P R Gersons; EA van Royen
Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study.
Psychopharmacology 2001;155(1):107-9.
2001: Hein J Verberne; Jan B A Habraken; EA van Royen; M M Tiel- van Buul; Jan J Piek; Berthe L F van Eck-Smit; H J Verbeme
Quantitative analysis of 99Tcm-sestamibi myocardial perfusion SPECT using a three-dimensional reference heart: a comparison with experienced observers.
Nuclear medicine communications 2001;22(2):155-63.
2001: Jules Lavalaye; Don Linszen; Jan Booij; Peter M A J Dingemans; Liesbeth Reneman; Jan B A Habraken; Berthold P R Gersons; EA van Royen
Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.
Schizophrenia research 2001;47(1):59-67.
2001: Ania Winogrodzka; PL Bergmans; Jan Booij; EA van Royen; Anton G M Janssen; Erik C Wolters
[123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(8-9):1011-9.
2000: Jules Lavalaye; Jan Booij; Liesbeth Reneman; Jan B A Habraken; EA van Royen
Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers.
European journal of nuclear medicine 2000;27(7):867-9.
2000: T S Benamer; Jim Patterson; Donald G Grosset; Jan Booij; Kora de Bruin; EA van Royen; Johannes D Speelman; Martin Horstink; H J Sips; R A Dierckx; Jan Versijpt; Danny Decoo; C Van Der Linden; Donald M Hadley; M Doder; Andrew J Lees; Durval C Costa; Svetislav Gacinovic; Wolfgang H Oertel; Oliver Pogarell; Helmut Hoeffken; K Joseph; K Tatsch; Johannes Schwarz; V Ries
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):503-10.
2000: JJ Claus; Bram Ongerboer de Visser; Lo J Bour; Gerard J Walstra; Albert Hijdra; Bernard Verbeeten; EA van Royen; Vincent I H Kwa; Willem A van Gool
Determinants of quantitative spectral electroencephalography in early Alzheimer's disease: cognitive function, regional cerebral blood flow, and computed tomography.
Dementia and geriatric cognitive disorders 2000;11(2):81-9.
2000: MA Hollants-Gilhuijs; Jan De Munck; Z Kubova; EA van Royen; Henk Spekreijse
The development of hemispheric asymmetry in human motion VEPs.
Vision research 2000;40(1):1-11.
1999: Jules Lavalaye; Don Linszen; Jan Booij; Liesbeth Reneman; Berthold P R Gersons; EA van Royen
Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
Psychiatry research 1999;92(1):33-44.
1999: Hein J Verberne; Jan J Piek; Rob A M van Liebergen; Karel T Koch; JM Schroeder-Tanka; EA van Royen
Functional assessment of coronary artery stenosis by doppler derived absolute and relative coronary blood flow velocity reserve in comparison with (99m)Tc MIBI SPECT.
Heart (British Cardiac Society) 1999;82(4):509-14.
1999: Jan B A Habraken; Jan Booij; P Slomka; Ellinor Busemann Sokole; EA van Royen
Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(7):1091-7.
1999: Jan Booij; T G Hemelaar; Johannes D Speelman; Kora de Bruin; Anton G M Janssen; EA van Royen
One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(5):753-61.
1999: JJ Claus; Gerard J Walstra; Albert Hijdra; EA van Royen; Bernard Verbeeten; Willem A van Gool
Measurement of temporal regional cerebral perfusion with single-photon emission tomography predicts rate of decline in language function and survival in early Alzheimer's disease.
European journal of nuclear medicine 1999;26(3):265-71.
1999: Jan Booij; G Tissingh; Ania Winogrodzka; EA van Royen
Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.
European journal of nuclear medicine 1999;26(2):171-82.
1998: Jan Booij; Remco J J Knol; Liesbeth Reneman; Kora de Bruin; Anton G M Janssen; EA van Royen
Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats.
European journal of nuclear medicine 1998;25(12):1666-9.
1998: Leonie J Rijks; Jan C van den Bos; PA van Doremalen; GJ Boer; Kora de Bruin; Anton G M Janssen; EA van Royen
New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Nuclear medicine and biology 1998;25(8):791-8.
1998: Jan C van den Bos; Leonie J Rijks; PA van Doremalen; Kora de Bruin; Anton G M Janssen; EA van Royen
New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 1: Synthesis and in vitro pharmacological characterization.
Nuclear medicine and biology 1998;25(8):781-9.
1998: Jan Booij; Jan B A Habraken; PL Bergmans; G Tissingh; Ania Winogrodzka; Erik C Wolters; Anton G M Janssen; JC Stoof; EA van Royen
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1879-84.
1998: Maarten C C M Hulshof; C J Rehmann; J Booij; EA van Royen; D Andries Bosch; Dionisio González González
Lack of perfusion enhancement after administration of nicotinamide and carbogen in patients with glioblastoma: a 99mTc-HMPAO SPECT study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;48(2):135-42.
1998: G Tissingh; Jan Booij; PL Bergmans; Ania Winogrodzka; Anton G M Janssen; EA van Royen; JC Stoof; Erik C Wolters
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(7):1143-8.
1998: Leonie J Rijks; Jan C van den Bos; PA van Doremalen; GJ Boer; Kora de Bruin; T Doornbos; Jef A J M Vekemans; M A Posthumus; Anton G M Janssen; EA van Royen
Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Nuclear medicine and biology 1998;25(4):411-21.
1998: MM Tiel-van Buul; Daniel C Aronson; Jaap W Groothoff; Robertine van Baren; Joost Frenkel; EA van Royen
The role of renal scintigraphy in the diagnosis and follow-up of unilateral ATN after complete bilateral distal ureteral obstruction as a complication of acute appendicitis.
Clinical nuclear medicine 1998;23(3):141-5.
1998: G Tissingh; PL Bergmans; Jan Booij; Ania Winogrodzka; EA van Royen; JC Stoof; Erik C Wolters
Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.
Journal of neurology 1998;245(1):14-20.
1998: Leonie J Rijks; Ellinor Busemann Sokole; M G Stabin; Kora de Bruin; Anton G M Janssen; EA van Royen
Biodistribution and dosimetry of iodine-123-labelled Z-MIVE: an oestrogen receptor radioligand for breast cancer imaging.
European journal of nuclear medicine 1998;25(1):40-7.
1998: Jan Booij; Ellinor Busemann Sokole; M G Stabin; Anton G M Janssen; Kora de Bruin; EA van Royen
Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
European journal of nuclear medicine 1998;25(1):24-30.
1997: Jan Booij; Gerda Andringa; Leonie J Rijks; RJ Vermeulen; Kora de Bruin; GJ Boer; Anton G M Janssen; EA van Royen
[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
Synapse (New York, N.Y.) 1997;27(3):183-90.
1997: Linda roolker; MM Tiel-van Buul; AH Broekhuizen; A K Eikelenboom; EA van Royen
Improved wrist fracture localization with digital overlay of bone scintigrams and radiographs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1600-3.
1997: G Tissingh; PL Bergmans; Jan Booij; Ania Winogrodzka; JC Stoof; Erik C Wolters; EA van Royen
[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.
European journal of nuclear medicine 1997;24(9):1171-4.
1997: Jules Lavalaye; JM Schroeder-Tanka; MM Tiel-van Buul; Ernst E van der Wall; Kong I Lie; EA van Royen
Implementation of technetium-99m MIBI SPECT imaging guidelines: optimizing the two day stress-rest protocol.
International journal of cardiac imaging 1997;13(4):331-5.
1997: JM Schroeder-Tanka; MM Tiel-van Buul; Ernst E van der Wall; Linda roolker; Kong I Lie; EA van Royen
Should imaging at stress always be followed by imaging at rest in Tc-99m MIBI SPECT? A proposal for a selective referral and imaging strategy.
International journal of cardiac imaging 1997;13(4):323-9.
1997: M Petjak; MM Tiel-van Buul; Chris R. Staalman; J C Greve; Jan de Kraker; EA van Royen
Diagnostic imaging in abdominal neuroblastoma: is there a complementary role of MIBG-scintigraphy and ultrasonography?
European journal of pediatrics 1997;156(8):610-5.
1997: G Tissingh; PL Bergmans; Ania Winogrodzka; JC Stoof; Erik C Wolters; Jan Booij; EA van Royen
Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1271-2.
1997: Leonie J Rijks; P J M Bakker; Geertjan van Tienhoven; LA Noorduyn; GJ Boer; RC Rietbroek; Carlo W Taat; Anton G M Janssen; Cindy Veenhof; EA van Royen
Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(7):2536-45.
1997: Jan Booij; P Korn; Don Linszen; EA van Royen
Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography.
European journal of nuclear medicine 1997;24(6):674-7.
1997: JJ Claus; E A Dubois; Jan Booij; Jan B A Habraken; Jan De Munck; Marcel van Herk; Bernard Verbeeten; EA van Royen
Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
European journal of nuclear medicine 1997;24(6):602-8.
1997: Jan Booij; G Tissingh; GJ Boer; Johannes D Speelman; JC Stoof; Anton G M Janssen; Erik C Wolters; EA van Royen
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;62(2):133-40.
1997: G Tissingh; Jan Booij; Ania Winogrodzka; EA van Royen; Erik C Wolters
IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism.
Journal of neural transmission. Supplementum 1997;50():31-7.
1997: Leonie J Rijks; GJ Boer; E Endert; Kora de Bruin; Anton G M Janssen; EA van Royen
The Z-isomer of 11 beta-methoxy-17 alpha-[123I]iodovinylestradiol is a promising radioligand for estrogen receptor imaging in human breast cancer.
Nuclear medicine and biology 1997;24(1):65-75.
1997: E A Dubois; G Aernout Somsen; Jan C van den Bos; Anton G M Janssen; HD Batink; GJ Boer; EA van Royen; Martin Pfaffendorf; Pieter A van Zwieten
Development of radioligands for the imaging of cardiac beta-adrenoceptors using SPECT. Part II: Pharmacological characterization in vitro and in vivo of new 123I-labeled beta-adrenoceptor antagonists.
Nuclear medicine and biology 1997;24(1):9-13.
1997: Jan C van den Bos; PA van Doremalen; E A Dubois; G Aernout Somsen; Jef A J M Vekemans; Anton G M Janssen; GJ Boer; Martin Pfaffendorf; EA van Royen; Pieter A van Zwieten
Development of radioligands for the imaging of cardiac beta-adrenoceptors using SPECT. Part I: Asymmetric synthesis and structural characterization of five new iodine-containing beta-adrenoceptor antagonist derivatives.
Nuclear medicine and biology 1997;24(1):1-7.
1997: Jan Booij; G Tissingh; Ania Winogrodzka; GJ Boer; JC Stoof; Erik C Wolters; EA van Royen
Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
European journal of nuclear medicine 1997;24(1):68-71.
1996: G Aernout Somsen; Ernst E van der Wall; B van Vlies; J J Borm; EA van Royen
Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.
International journal of cardiac imaging 1996;12(4):305-10.
1996: G Aernout Somsen; J J Borm; E A Dubois; M B Schook; Ernst E van der Wall; EA van Royen
Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies.
Nuclear medicine communications 1996;17(10):872-6.
1996: G Aernout Somsen; B van Vlies; P A de Milliano; J J Borm; EA van Royen; Erik Endert; Kong I Lie
Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.
Heart (British Cardiac Society) 1996;76(3):218-22.
1996: EA van Royen; Nicolaas P L G Verhoeff; SA Meylaerts; A R Miedema
Indium-111-DTPA-octreotide uptake measured in normal and abnormal pituitary glands.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1449-51.
1996: E A Dubois; Jan C van den Bos; T Doornbos; PA van Doremalen; G Aernout Somsen; Jef A J M Vekemans; Anton G M Janssen; HD Batink; G J Boer; Martin Pfaffendorf; EA van Royen; Pieter A van Zwieten
Synthesis and in vitro and in vivo characteristics of an iodinated analogue of the beta-adrenoceptor antagonist carazolol.
Journal of medicinal chemistry 1996;39(17):3256-62.
1996: E A Dubois; K L Kam; G Aernout Somsen; G J Boer; Kora de Bruin; HD Batink; Martin Pfaffendorf; EA van Royen; Pieter A van Zwieten
Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
European journal of nuclear medicine 1996;23(8):901-8.
1996: Leonie J Rijks; Jan Booij; T Doornbos; G J Boer; E Ronken; Kora de Bruin; R J Vermeulen; Anton G M Janssen; EA van Royen
In vitro and in vivo characterization of newly developed iodinated 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine derivatives in rats: limited value as dopamine transporter SPECT ligands.
Synapse (New York, N.Y.) 1996;23(3):201-7.
1996: S F Vervoordeldonk; J Heikens; W T Goedemans; P A Merle; Albert E G Kr von dem Borne; EA van Royen; Ineke Slaper-Cortenbach; R H van Oers
99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin's lymphoma.
Cancer immunology, immunotherapy : CII 1996;42(5):291-6.
1996: E A Dubois; G Aernout Somsen; Jan C van den Bos; Anton G M Janssen; G J Boer; HD Batink; EA van Royen; Martin Pfaffendorf; Pieter A van Zwieten
Pharmacologic characterization in vitro and in vivo of iodine 123-labeled derivatives of the beta-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac beta-receptors.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 1996;3(3):242-52.
1996: Leonie J Rijks; G J Boer; E Endert; Kora de Bruin; Jan C van den Bos; PA van Doremalen; W G Schoonen; Anton G M Janssen; EA van Royen
The stereoisomers of 17alpha-[123I]iodovinyloestradiol and its 11beta-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats.
European journal of nuclear medicine 1996;23(3):295-307.
1996: G Aernout Somsen; E A Dubois; K Brandsma; J de Jong; Pol A van der Wouw; HD Batink; EA van Royen; Kong I Lie; Pieter A van Zwieten
Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
Cardiovascular research 1996;31(1):132-8.
1996: J M Schroeder-Tanka; MM Tiel-van Buul; Ernst E van der Wall; Kong I Lie; EA van Royen
Limited value of stress electrocardiographic changes in predicting late 201Tl reversibility: do all patients need reinjection?
Nuclear medicine communications 1996;17(1):15-9.
1995: R J Vermeulen; Erik C Wolters; G Tissingh; Jan Booij; Anton G M Janssen; Jan B A Habraken; E Sokole-Busemann; JC Stoof; EA van Royen
Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.
Nuclear medicine and biology 1995;22(8):985-91.
1995: G Aernout Somsen; J J Borm; P A de Milliano; B van Vlies; E A Dubois; EA van Royen
Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference.
European journal of nuclear medicine 1995;22(10):1149-54.
1995: Willem A van Gool; Gerard J Walstra; S Teunisse; F M Van der Zant; H C Weinstein; EA van Royen
Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography.
Journal of neurology 1995;242(6):401-5.
1995: J J Borm; Marco J Bruno; J J de Goeij; T F Moest; EA van Royen
Dosimetric optimization of postproduction neutron-activated erbium-170-oxide-enriched pancreatin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(5):888-92.
1994: Edwin J R Van Beek; MM Tiel-van Buul; C A Hoefnagel; H H Jagt; EA van Royen
Reporting of perfusion/ventilation lung scintigraphy using an anatomical lung segment chart: a prospective study.
Nuclear medicine communications 1994;15(9):746-51.
1994: J K Anninga; Renato A Valdés Olmos; Jan de Kraker; H van Tinteren; C A Hoefnagel; EA van Royen
Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer.
European journal of nuclear medicine 1994;21(7):658-62.
1994: R J Vermeulen; Benjamin Drukarch; Nicolaas P L G Verhoeff; C Goosen; M C Sahadat; Erik C Wolters; EA van Royen; JC Stoof
No direct correlation between behaviorally active doses of the dopamine D2 agonist LY 171555 and displacement of [123I]IBZM as measured with SPECT in MPTP monkeys.
Synapse (New York, N.Y.) 1994;17(2):115-24.
1994: F J Bemelman; K J Parlevliet; P T A Schellekens; Sugianto Surachno; EA van Royen; R J ten Berge
Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependent.
Transplant immunology 1994;2(1):47-51.
1993: Nicolaas P L G Verhoeff; O Kapucu; E Sokole-Busemann; EA van Royen; Anton G M Janssen
Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(12):2076-84.
1993: Nicolaas P L G Verhoeff; W H Visser; M D Ferrari; P R Saxena; EA van Royen
Dopamine D2-receptor imaging with 123I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier?
Cephalalgia : an international journal of headache 1993;13(5):325-9.
1993: Nicolaas P L G Verhoeff; E B Sokole; M Stabin; D Hengst; H F Kung; EA van Royen; Anton G M Janssen
Dosimetry of iodine-123 iodobenzamide in healthy volunteers.
European journal of nuclear medicine 1993;20(9):747-52.
1993: Nicolaas P L G Verhoeff; Belkis Erbas; O Kapucu; Ellinor Busemann Sokole; H Blok; EA van Royen
Quantification of central benzodiazepine receptor binding potential in the brain with 123I-iomazenil SPECT: technical and interobserver variability.
Nuclear medicine communications 1993;14(8):634-43.
1993: Nicolaas P L G Verhoeff; Ellinor Busemann Sokole; D Hengst; J B Stubbs; EA van Royen
Dosimetry of iodine-123 iomazenil in humans.
European journal of nuclear medicine 1993;20(7):580-4.
1993: MM Tiel-van Buul; Edwin J R Van Beek; J J Borm; F M Gubler; AH Broekhuizen; EA van Royen
The value of radiographs and bone scintigraphy in suspected scaphoid fracture. A statistical analysis.
Journal of hand surgery (Edinburgh, Scotland) 1993;18(3):403-6.
1993: H C Weinstein; Philip scheltens; Albert Hijdra; EA van Royen
Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.
Clinical neurology and neurosurgery 1993;95(2):81-91.
1993: Nicolaas P L G Verhoeff; F J Bemelman; Wilmar M Wiersinga; EA van Royen
Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.
European journal of nuclear medicine 1993;20(6):555-61.
1993: M H Raasveld; F J Bemelman; P T A Schellekens; Frank N J van Diepen; A van Dongen; EA van Royen; C Erik Hack; Ineke J M ten Berge
Complement activation during OKT3 treatment: a possible explanation for respiratory side effects.
Kidney international 1993;43(5):1140-9.
1993: EA van Royen; Nicolaas P L G Verhoeff; J D Speelman; Erik C Wolters; M A Kuiper; Anton G M Janssen
Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.
Archives of neurology 1993;50(5):513-6.
1993: Edwin J R Van Beek; MM Tiel-van Buul; Harry R Büller; EA van Royen; JW ten Cate
The value of lung scintigraphy in the diagnosis of pulmonary embolism.
European journal of nuclear medicine 1993;20(2):173-81.
1993: MM Tiel-van Buul; Edwin J R Van Beek; P F Dijkstra; A J Bakker; T H Broekhuizen; EA van Royen
Significance of a hot spot on the bone scan after carpal injury--evaluation by computed tomography.
European journal of nuclear medicine 1993;20(2):159-64.
1993: Nicolaas P L G Verhoeff; A Bekier; H F Beer; P August Schubiger; P Fennema; EA van Royen
123I-SCH 23982 is not suitable for dopamine D1 receptor imaging in vivo in the human brain.
Nuclear medicine communications 1993;14(2):137-44.
1993: Vincent I H Kwa; H C Weinstein; E F Posthumus Meyjes; EA van Royen; Lo J Bour; P N Verhoeff; Bram Ongerboer de Visser
Spectral analysis of the EEG and 99m-Tc-HMPAO SPECT-scan in Alzheimer's disease.
Biological psychiatry 1993;33(2):100-7.
1993: MM Tiel-van Buul; Edwin J R Van Beek; AH Broekhuizen; A J Bakker; Kurt E Bos; EA van Royen
Radiography and scintigraphy of suspected scaphoid fracture. A long-term study in 160 patients.
The Journal of bone and joint surgery. British volume 1993;75(1):61-5.
1992: Nicolaas P L G Verhoeff; Albert P Aldenkamp; J Overweg; EA van Royen; B Verbeeten; H C Weinstein
Memory complaints, memory disorders and focus localization in patients with partial epilepsy.
Seizure : the journal of the British Epilepsy Association 1992;1(3):149-56.
1992: Nicolaas P L G Verhoeff; H C Weinstein; Albert P Aldenkamp; J Overweg; EA van Royen; B Verbeeten
Focus localization in patients with partial epilepsy with 99Tcm-HMPAO SPECT under continuous surface EEG monitoring.
Nuclear medicine communications 1992;13(3):127-36.
1992: MM Tiel-van Buul; Edwin J R Van Beek; A van Dongen; EA van Royen
The reliability of the 3-phase bone scan in suspected scaphoid fracture: an inter- and intraobserver variability analysis.
European journal of nuclear medicine 1992;19(10):848-52.
1991: Nicolaas P L G Verhoeff; T Brücke; I Podreka; M Bobeldijk; P Angelberger; EA van Royen
Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with 123I-IBZM using the rotating gamma camera.
Nuclear medicine communications 1991;12(8):687-97.
1991: MM Tiel-van Buul; Chris J J Mulder; EA van Royen; E H Wiltink; G N J Tytgat
Retrograde spread of mesalazine (5-aminosalicylic acid)-containing enema in patients with ulcerative colitis.
Clinical pharmacokinetics 1991;20(3):247-51.
1991: Nicolaas P L G Verhoeff; M Bobeldijk; M G Feenstra; G J Boer; MA Maas; E Erdtsieck-Ernste; Kora de Bruin; EA van Royen
In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(8):837-46.
1991: H C Weinstein; Albert Hijdra; EA van Royen; M M Derix; Gerard J Walstra; Cees Jonker
SPECT in early- and late-onset Alzheimer's disease.
Annals of the New York Academy of Sciences 1991;640():72-3.
1990: Udalrich Buell; D C Costa; G Kirsch; J L Moretti; EA van Royen; Otmar Schober
The investigation of dementia with single photon emission tomography.
Nuclear medicine communications 1990;11(12):823-41.
1990: B van Vlies; EA van Royen; Cees A Visser; N G Meyne; M M van Buul; Ron J G Peters; A J Dunning
Frequency of myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass grafting.
The American journal of cardiology 1990;66(17):1191-5.
1990: M Limburg; EA van Royen; Albert Hijdra; J F de Bruïne; B W Verbeeten
Single-photon emission computed tomography and early death in acute ischemic stroke.
Stroke; a journal of cerebral circulation 1990;21(8):1150-5.
1990: Durval C Costa; Nicolaas P L G Verhoeff; I D Cullum; Peter J Ell; G M Syed; J Barrett; E Palazidou; B Toone; EA van Royen; M Bobeldijk
In vivo characterisation of 3-iodo-6-methoxybenzamide 123I in humans.
European journal of nuclear medicine 1990;16(11):813-6.
1990: B van Vlies; J Baas; Cees A Visser; EA van Royen; B J Delemarre; H Bot; A J Dunning
Early Indium-111 antimyosin scintigraphy for assessment of regional wall motion asynergy on discharge after myocardial infarction.
International journal of cardiac imaging 1990;5(4):241-8.
1990: J F de Bruïne; M Limburg; EA van Royen; Albert Hijdra; T C Hill; J B van der Schoot
SPET brain imaging with 201 diethyldithiocarbamate in acute ischaemic stroke.
European journal of nuclear medicine 1990;17(5):248-51.
1989: Joost Haan; H C Weinstein; M J van Kroonenburgh; EA van Royen; J B Lanser; M Derix; O J Buruma; Albert Hijdra
Single photon emission computed tomography in Alzheimer's disease.
Archives of neurology 1989;46(11):1165-6.
1989: M M van Buul; Chris J J Mulder; E H Wiltink; EA van Royen; G N J Tytgat
Retrograde spread of therapeutic enemas in patients with inflammatory bowel disease.
Hepato-gastroenterology 1989;36(4):199-201.
1989: B van Vlies; J Baas; Cees A Visser; EA van Royen; B J Delemarre; H Bot; A J Dunning
Predictive value of indium-111 antimyosin uptake for improvement of left ventricular wall motion after thrombolysis in acute myocardial infarction.
The American journal of cardiology 1989;64(3):167-71.
1989: H C Weinstein; Albert Hijdra; EA van Royen; M M Derix
Determination of cerebral blood flow by SPECT: a valuable tool in the investigation of dementia?
Clinical neurology and neurosurgery 1989;91(1):13-9.
1987: EA van Royen
Thallium-201 DDC, an alternative radiopharmaceutical for rCBF.
Nuclear medicine communications 1987;8(7):603-10.
1987: EA van Royen; J F de Bruïne; T C Hill; A Vyth; M Limburg; B L Byse; D H O'Leary; J M de Jong; Albert Hijdra; J B van der Schoot
Cerebral blood flow imaging with thallium-201 diethyldithiocarbamate SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(2):178-83.
1986: J F de Bruïne; EA van Royen; F van Weeren; F A vd Weel; S Reiffers; B W Verbeeten; H Krens; Albert Hijdra; M Limburg
Functional brain imaging with I123-amphetamine. First experience in the Netherlands.
Clinical neurology and neurosurgery 1986;88(4):253-61.
1985: J F de Bruine; EA van Royen; A Vyth; J M de Jong; J B van der Schoot
Thallium-201 diethyldithiocarbamate: an alternative to iodine-123 N-isopropyl-p-iodoamphetamine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(8):925-30.